Adenocarcinoma
2 competing products in clinical development for Adenocarcinoma.
Pipeline by Phase
Phase 11
Phase 31
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Bevacizumab + Capecitabine + Cisplatin + Placebo + 5-fluorouracil | Chugai Pharmaceutical | Phase 3 | Completed | 40 |
| Ramucirumab (IMC-1121B ) + Paclitaxel | Eli Lilly | Phase 1 | Completed | 29 |